Stingl, G; Bröcker, EB; Mertelsmann, R; Wolff, K; Schreiber, S; Kämpgen, E; Schneeberger, A; Trcka, J; Brennscheidt, U; Veelken, H; Birnstiel, ML; Zatloukal, K; Maass, G; Wagner, E; Buschle, M; Kempe, ER; Weber, HA; Voigt, T.
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
J Mol Med. 1997; 75(4):297-299
Doi: 10.1007%2Fs001090050115
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar